Roche Tissue Diagnostics, is one of the world’s leading cancer diagnostic companies and is an innovator of tissue-based tests that enable the delivery of Personalized Healthcare to cancer patients.
The company known as Ventana Medical Systems, Inc., founded by Thomas Grogan, M.D., Professor of Pathology, University of Arizona, established the concept of a single, complete report covering all aspects of a patient’s case, which helps to improve survivability.
Roche Tissue Diagnostics is passionate about its mission to improve the lives of all patients afflicted with cancer by developing and delivering medical diagnostic systems and tissue-based cancer tests that are shaping the future of healthcare. Ventana products provide healthcare professionals with a comprehensive solution for the critical steps involved in the analysis of tissue samples.
In addition, Roche Tissue Diagnostics offers premier workflow solutions specially designed to improve laboratory efficiency and protect patient safety.
Recognizing the world’s increasing medical needs, Roche Tissue Diagnostics focuses on accelerating the discovery and development of new prognostic and predictive cancer tests that help enable Personalized Healthcare. These tests allow pathologists to analyze patient samples at the molecular, cellular and tissue level to help determine the best course of therapy for individual patients.
For more information please visit www.ventana.com
VENTANA HE 600 system
BenchMark Special Stains instrument
VENTANA BenchMark IHC/ISH systems
* H&E = Hematoxylin and Eosin, ISH = In situ Hybridisation, IHC= Immunohistochemistry, SpSt = Special stains